RevMedx

What RevMedx does

RevMedX (legal entity RevMedx, Inc.) is a privately held specialty medical device company headquartered at 25749 SW Canyon Creek Rd Suite 300, Wilsonville, Oregon, that designs, develops, and manufactures hemorrhage control products for prehospital, tactical, and battlefield use. The company's core technology is a proprietary expandable minisponge (cellulose-based) hemostatic platform in which compressed sponges expand up to 10x upon contact with blood to fill wound cavities and apply internal hemostatic pressure without manual compression. This platform underpins the FDA-cleared XSTAT P30 ($299 per pack) and XSTAT P15 ($92 per pack) injectable devices — indicated respectively for severe junctional bleeding (axilla/groin) and narrow-entrance extremity wounds — and the over-the-counter XGAUZE Trauma Pad ($79). RevMedX also sells the CoTCCC-recommended TX Series ratcheting tourniquets (TX2 at $39.95, TX3 at $35, TX-XL at $43.50) and the AirWrap compression bandage and SharkBite Blast Injury Kit sub-brands.

The company monetizes through a hybrid go-to-market: a Shopify-powered direct e-commerce storefront for OTC and prescription (medical-authorization-gated) sales with multi-currency checkout across 28 listed countries; federal government procurement via the authorized distributor Integrated Medcraft using assigned National Stock Numbers; regional Military Health System distribution through Panakeia, LLC; and a wholesale/distributor inquiry process for bulk and international orders. Products are ISO 13485 certified, FDA 21 CFR Part 820 compliant, CE marked where applicable, and developed in collaboration with the U.S. Military, with XSTAT field-tested by U.S. Special Operations Forces for over a decade. Revenue, funding totals, and ownership structure beyond the 2013 Saving Lives at Birth Grand Challenge grant (USAID/Gates) and an undisclosed 2014 U.S. Military arrangement are not publicly disclosed; no venture capital or private equity investors are named in the source data.

Name

RevMedx

Legal name

RevMedx, Inc.

Website

https://revmedx.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

RevMedX is a privately held medical device company that designs, develops, and manufactures FDA-cleared expandable minisponge hemorrhage control products (XSTAT, XGAUZE) and CoTCCC-recommended TX Series ratcheting tourniquets for U.S. Military medics, tactical law enforcement, EMS providers, and civilian first responders.

Ownership category

akta.pro rank

Product category

Hemorrhage Control Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)

akta.pro secondary industry

First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care) (CRADAMAB)

Keywords

• Hemorrhage control devices
• Trauma care products
• Hemostatic medical devices
• Military medical supplies
• Prehospital emergency care

Headquarters

HQ city

Wilsonville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Product Sales: Direct product sales of hemorrhage control devices including XSTAT injectors, XGAUZE trauma pads, and TX tourniquets through e-commerce, prescription channel, and OTC channel.
2. Prescription Device Sales: Sales of FDA-cleared XSTAT P30 and XSTAT P15 through authorized medical professional channels requiring medical license verification and Rx approval.
3. Over-the-Counter Products: Direct consumer sales of OTC trauma products including XGAUZE Trauma Pad and TX tourniquets through e-commerce platform.
4. Federal Government Procurement: Government sales through authorized distributor Integrated Medcraft for U.S. federal government procurement, including military and emergency services.
5. Wholesale and Bulk Distribution: Wholesale and bulk ordering through distributor network, including international distribution opportunities.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

Core offering

RevMedx designs, develops, and manufactures innovative medical devices for prehospital and battlefield hemorrhage control. Its core offerings include the XSTAT line of injectable hemostatic devices that use compressed cellulose minisponges which expand up to 10x on blood contact to stop junctional and extremity bleeding, the XGAUZE expanding sponge trauma dressing, and the TX Series ratcheting tourniquets. Products are FDA-cleared, CoTCCC-recommended, and sold directly to medical professionals, military units, law enforcement, EMS, and civilian consumers.

Product overview

RevMedX is a medical device company focused on hemorrhage control products. The product line consists of two main categories: injectable hemostatic devices (XSTAT® line including P30 and P15) that use expanding minisponge technology for junctional wounds, and TX Series ratcheting tourniquets (TX2, TX3, TX-XL) for limb hemorrhage control. Supporting products include XGAUZE® Trauma Pad, an OTC expanding sponge dressing. All products are designed for military, tactical, and civilian first responder use.

Differentiator

Problem solved

Functional benefit

Brands

• XSTAT: Injectable hemostatic system for severe junctional bleeding using rapidly expanding sponge pouches
• XGAUZE
• TX Series
• AirWrap

Products and services

• XSTAT® P30 FDA-cleared injectable hemostatic device for severe junctional bleeding; uses syringe-style applicator to inject rapidly expanding sponge pouches that absorb blood and expand up to 10x, applying internal pressure to stop bleeding in seconds. Restricted by federal law to sale by or on the order of a physician; priced at $299.00 per single pack.
• XSTAT® P15 FDA-cleared hemostatic device with reduced-diameter applicator optimized for narrow-entrance wounds (e.g., gunshot, shrapnel injuries); delivers one minisponge pouch per applicator for controlled placement. Restricted by federal law to sale by or on the order of a physician; priced at $92.00 per single pack.
• XGAUZE® Trauma Pad Over-the-counter hemostatic dressing using expanding minisponge technology in a compact 4\"x4\" pad; cellulose-based minisponges expand up to 10x on contact with blood; 5-year shelf life; priced at $79.00 per unit.
• TX2 Ratcheting Tourniquet CoTCCC-recommended 2-inch wide ratcheting tourniquet for rapid limb hemorrhage control with self-locking ratchet mechanism, one-handed application, and durable construction for repeated training use; UV-resistant MILSPEC webbing with no expiration date; priced at $39.95 per unit; FSA/HSA eligible.
• TX3 Ratcheting Tourniquet CoTCCC-recommended 3-inch wide ratcheting tourniquet, the widest non-pneumatic tourniquet on the recommended list; designed for prolonged field care with reduced tissue and nerve damage; available in 40\" and 60\" lengths; starting price $35.00 per unit.
• TX-XL Ratcheting Tourniquet Extra large CoTCCC-recommended ratcheting tourniquet for limb hemorrhage control with minimal training; features buckle-and-ratchet system for precise compression under stress or with one hand; priced at $43.50 per unit; FSA/HSA eligible.

Quantifiable outcome

• Minisponges expand up to 10x their compressed size within seconds of blood contact
• +4 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core.

• U.S. MilitarycoreStrategic or Co-development Partner · 16 April 2015RevMedX collaborated with the U.S. military to develop XSTAT devices specifically for battlefield hemorrhage control. The first commercial shipment of XSTAT was made to the U.S. Military in April 2015, marking the first complete production run and global market availability. Products developed with direct input from military medics and first responders.
• Panakeia, LLCcoreChannel Partner/ Reseller/ Distributor · 30 August 2013Panakeia, LLC serves as a distribution partner for RevMedX's AirWrap product, promoting and distributing to the Military Health System. Based in Fayetteville, North Carolina and Stafford, Virginia, Panakeia focuses on healthcare solutions distribution to military medical channels.
• Oregon Health and Science University (OHSU)coreStrategic or Co-development Partner · 30 July 2013OHSU and RevMedX jointly received a USAID/Gates Foundation seed grant through the Saving Lives at Birth Grand Challenge to develop a novel treatment for postpartum hemorrhage based on RevMedX's XSTAT technology. Selected from over 400 submissions as part of international effort to reduce maternal and neonatal deaths.
• Integrated MedcraftcoreChannel Partner/ Reseller/ DistributorIntegrated Medcraft serves as the authorized distributor for RevMedX products to U.S. federal government customers. Government customers must order through this channel for federal procurement including military and emergency services purchasing.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Stryker: Stryker is a diversified medical device giant with relevant hemorrhage control and emergency/trauma products, including hemostatic agents and surgical supplies. Competes indirectly as a broad incumbent with greater R&D resources and distribution scale.
• Becton Dickinson (BD): BD is a global medical technology incumbent with extensive surgical hemostasis and wound care portfolios. While not solely focused on tactical hemorrhage control, BD's scale and government sales infrastructure make it a competitor for hospital and large-system contracts.
• Teleflex: Teleflex is a large medical device incumbent that markets tactical/EMS hemorrhage control products including hemostatic dressings and tourniquets. Sells to military, EMS, and hospital channels with a broader product portfolio than RevMedX.

Direct peers

• Z-Medica (QuikClot): Z-Medica is a direct competitor in hemostatic dressings and gauzes, selling the widely adopted QuikClot combat gauze line to military and civilian first responders. Operates in the same hemorrhage control category with overlapping customer base in tactical and EMS markets.
• Celox Medical: Celox manufactures chitosan-based hemostatic gauze and granules marketed for military and civilian trauma care, directly competing with XSTAT and XGAUZE. Holds CE Mark and FDA clearances and is sold through U.S. and NATO military channels.
• North American Rescue: North American Rescue is a leading supplier of tactical combat casualty care and EMS products including hemostatic dressings and tourniquets, with deep military procurement relationships similar to RevMedX. Competes head-to-head in federal supply chain and civilian first-responder kits.
• Combat Medical Systems: Combat Medical Systems designs and distributes tactical combat casualty care products including hemostatic dressings and tourniquets. Directly comparable niche medical device player serving military, law enforcement, and EMS customers.
• Tricol Biomedical: Tricol Biomedical manufactures the HemCon chitosan-based hemostatic bandages used in military and civilian trauma kits. Competes directly with XGAUZE in the OTC and tactical hemostatic dressing segment.
• SAM Medical Products: SAM Medical Products manufactures the widely adopted SAM XT tourniquet and related trauma medical devices. Directly comparable in tourniquet product category and shares the tactical/EMS/military customer base with RevMedX's TX Series.

Emerging players

• Mercer Group (CRD): Mercer Medical and similar emerging tactical/EMS medical device firms develop hemostatic and trauma products for civilian and military markets, representing a class of smaller competitors in adjacent wound care categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/RevMedx
• YouTubeyoutube.com/@revmedxincorporated5757
• Facebookfacebook.com/RevMedx
• LinkedInlinkedin.com/company/revmedx-inc-

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RevMedx